Patient activation in individuals with type 2 diabetes mellitus: associated factors and the role of insulin by van Vugt HA, Boels AM, de Weerdt I, de Koning EJP, Rutten GEHM

Get full text

ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care by Berishvili, E, Piemonti, L, de Koning, EJP, Lindstedt, S, Scholz, H, Scott, WE, Auxenfans, C, Johnson, P, Martin, DE, Gunther, P, Mey, D, Potena, L, Thaunat, O

Defining outcomes for β-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA/EPITA opinion leaders workshop by Rickels, MR, Stock, PG, De Koning, EJP, Piemonti, L, Pratschke, J, Alejandro, R, Bellin, MD, Berney, T, Choudhary, P, Johnson, PR, Kandaswamy, R, Kay, TWH, Keymeulen, B, Kudva, YC, Latres, E, Langer, RM, Lehmann, R, Ludwig, B, Markmann, JF, Marinac, M, Odorico, JS, Pattou, F, Senior, PA, Shaw, JAM, Vantyghem, M-C, White, S